Tebipenem Pivoxil Hydrobromide (TBPM-PI-HBr) + Placebo
SPR994-104
Phase 1 small_molecule completed
Quick answer
Tebipenem Pivoxil Hydrobromide (TBPM-PI-HBr) + Placebo for TQT Study is a Phase 1 program (small_molecule) at Spero Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Spero Therapeutics
- Indication
- TQT Study
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed